CLINICAL TRIALS PROFILE FOR PEMETREXED DISODIUM
✉ Email this page to a colleague
All Clinical Trials for Pemetrexed Disodium
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003706 ↗ | LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function | Completed | Lily Research Laboratories | Phase 1 | 1998-04-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemotherapy drugs may have different effects in patients with different degrees of kidney function. PURPOSE: Phase I trial to study the effectiveness of LY231514 in treating patients who have locally advanced or metastatic solid tumors and varying degrees of kidney function. |
| NCT00003706 ↗ | LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function | Completed | National Cancer Institute (NCI) | Phase 1 | 1998-04-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemotherapy drugs may have different effects in patients with different degrees of kidney function. PURPOSE: Phase I trial to study the effectiveness of LY231514 in treating patients who have locally advanced or metastatic solid tumors and varying degrees of kidney function. |
| NCT00003706 ↗ | LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function | Completed | The University of Texas Health Science Center at San Antonio | Phase 1 | 1998-04-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemotherapy drugs may have different effects in patients with different degrees of kidney function. PURPOSE: Phase I trial to study the effectiveness of LY231514 in treating patients who have locally advanced or metastatic solid tumors and varying degrees of kidney function. |
| NCT00003711 ↗ | Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors | Completed | San Antonio Cancer Institute | Phase 1 | 1997-09-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy with pemetrexed disodium and irinotecan in treating patients who have metastatic solid tumors. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Pemetrexed Disodium
Condition Name
| Condition Name for Pemetrexed Disodium | |
| Intervention | Trials |
| Lung Cancer | 29 |
| Stage IV Non-Small Cell Lung Cancer | 14 |
| Unspecified Adult Solid Tumor, Protocol Specific | 9 |
| Stage IIIA Non-small Cell Lung Cancer | 9 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for Pemetrexed Disodium
Trials by Country
Clinical Trial Progress for Pemetrexed Disodium
Clinical Trial Phase
Clinical Trial Sponsors for Pemetrexed Disodium
Sponsor Name
